Ropes & Gray Advised Teva Pharmaceuticals in Proposed Acquisition of Novel Neuroscience Asset From BioXcel Therapeutics
August 29, 2026
August 29, 2026
BOSTON, Massachusetts, Aug. 29 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advised Teva Pharmaceuticals in Proposed Acquisition of Novel Neuroscience Asset from BioXcel Therapeutics
Ropes & Gray represented Teva Pharmaceuticals in its proposed acquisition of certain neuroscience assets from BioXcel Therapeutics, Inc. The transaction was announced on August 28.
Teva is acquiring the assets out of BioxCel& . . .
* * *
Ropes & Gray Advised Teva Pharmaceuticals in Proposed Acquisition of Novel Neuroscience Asset from BioXcel Therapeutics
Ropes & Gray represented Teva Pharmaceuticals in its proposed acquisition of certain neuroscience assets from BioXcel Therapeutics, Inc. The transaction was announced on August 28.
Teva is acquiring the assets out of BioxCel& . . .